谷歌浏览器插件
订阅小程序
在清言上使用

Efficacy and Safety of Biosimilar Trastuzumab (CT-P6) in Routine Clinical Practice in the Republic of Korea: a Real-World Post-Marketing Surveillance Study.

EXPERT OPINION ON BIOLOGICAL THERAPY(2024)

引用 0|浏览0
暂无评分
关键词
Anti-HER2,biosimilar,CT-P6,human epidermal growth receptor 2,post-marketing surveillance,trastuzumab
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要